Skip to main content

Want a detailed portfolio tracker?

NewAmsterdam Pharma (NAMS) P/E (2023 - 2026)

NewAmsterdam Pharma (NAMS) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM NewAmsterdam Pharma (NAMS) P/E is -17.38. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NewAmsterdam Pharma (NAMS)

YearP/EChange
2026-17.38-10.93%
2025-19.51+90.74%
2024-10.23+42.22%
2023-7.19N/A

Comparison NewAmsterdam Pharma (NAMS) P/E with competitors

NewAmsterdam Pharma (NAMS) P/E is -17.38.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.38%
CHRSCoherus Biosciences Inc0.85-104.88%
FBIOFortress Biotech Inc0.95-105.46%
ORMPOramed Pharmaceuticals Inc1.50-108.65%
AGENAgenus Inc3.01-117.32%
INVAInnoviva Inc3.15-118.15%
VXRTVaxart Inc3.55-120.42%
CRMDCorMedix Inc3.63-120.88%
CVACCureVac N.V.4.45-125.58%
GLPGGalapagos NV4.86-127.95%
SRPTSarepta Therapeutics Inc4.88-128.09%
ABEOAbeona Therapeutics Inc5.39-131.00%
ABUSArbutus Biopharma Corp5.60-132.19%
ZVRAZevra Therapeutics Inc5.89-133.87%
SPROSpero Therapeutics Inc6.23-135.83%
CGENCompugen Ltd6.31-136.33%
RIGLRigel Pharmaceuticals6.87-139.54%
SLXNSilexion Therapeutics Corp7.30-141.98%
OMEROmeros Corporation9.26-153.27%
AUPHAurinia Pharmaceuticals Inc9.58-155.14%
PLXProtalix BioTherapeutics Inc10.89-162.66%
ACADAcadia Pharmaceuticals Inc11.73-167.48%
TBPHTheravance Biopharma Inc12.26-170.55%
ADMAAdma Biologics Inc12.42-171.45%
HRMYHarmony Biosciences Holdings Inc13.82-179.51%
SABSSAB Biotherapeutics Inc14.14-181.33%
NAGENiagen Bioscience Inc14.82-185.25%
INCYIncyte Corp15.82-191.03%
REGNRegeneron Pharmaceuticals Inc15.86-191.23%
PBYIPuma Biotechnology Inc17.32-199.62%
CPRXCatalyst Pharmaceuticals Inc17.44-200.33%
EXELExelixis Inc17.54-200.90%
TGTXTG Therapeutics Inc18.97-209.12%
MDXGMimedx Group Inc20.55-218.24%
XOMAXOMA Royalty Corp22.87-231.61%
ARGXArgen X SE24.30-239.80%
CTMXCytomX Therapeutics Inc24.82-242.81%
XOMAOXOMA Royalty Corp25.34-245.82%
HALOHalozyme Therapeutics Inc25.62-247.42%
XOMAPXOMA Royalty Corp25.67-247.69%
VRTXVertex Pharmaceuticals Inc27.99-261.07%
RPRXRoyalty Pharma plc - Class A28.69-265.05%
SLNOSoleno Therapeutics Inc29.02-266.94%
ASNDAscendis Pharma A/S30.09-273.10%
LGNDLigand Pharmaceuticals Inc - Class B37.91-318.12%
APLSApellis Pharmaceuticals Inc39.02-324.51%
BMRNBiomarin Pharmaceutical Inc42.21-342.86%
KRYSKrystal Biotech Inc45.34-360.88%
ONCBeiGene Ltd69.54-500.10%
PHARPharming Group N.V.75.03-531.66%
TECHBio-Techne Corp101.96-686.61%
VCELVericel Corp109.92-732.43%
ALNYAlnylam Pharmaceuticals Inc117.96-778.71%
GMABGenmab140.29-907.16%
TLXTelix Pharmaceuticals Ltd162.15-1032.94%
CORTCorcept Therapeutics Inc212.86-1324.67%